-
Agile Therapeutics Receives Approximately $3 Million in Non-Dilutive Funding
Post on 12/1/16
-
What's Pfizer's Excuse for Not Buying Exelixis?
Post on 12/1/16
-
Johnson & Johnson Throws Caution to the Wind With a Large Bid for Actelion
Post on 12/1/16
-
Gamma Medica Announces New Partnership with Leading Medical Facility, Einstein Medical Center Philadelphia
Post on 11/30/16
-
Merck Boosts Dividend 2% And Has Several Key Growth Drivers
Post on 11/30/16
-
J&J - Approaching Value Territory, But I Am Not Waiting
Post on 11/30/16
-
Nabriva Announces Terms of Rights Offering
Post on 11/30/16
-
Celldex Therapeutics Completes Acquisition of Kolltan Pharmaceuticals
Post on 11/30/16
-
Aethon Announces Billings Clinic as Newest MedEx Customer
Post on 11/29/16
-
Celgene Stock Split: Is the Biotech Ready to Split Again?
Post on 11/29/16
-
Trumpcare Could Be a Disaster for America's Healthcare System -- Here's Why
Post on 11/29/16
-
ImMAGE Biotherapeutics Announces Positive Results from Animal Studies
Post on 11/28/16
-
Bellerophon Therapeutics Announces $12 Million Public Offering
Post on 11/23/16
-
Trumpcare Could Be a Disaster for America's Healthcare System -- Here's Why
Post on 11/22/16
-
Johnson & Johnson Takes Aim at AbbVie
Post on 11/21/16
-
Teva Pharmaceutical - Now Easy To Swallow
Post on 11/21/16
-
Better Buy: Celgene Corporation vs. Bristol-Myers Squibb
Post on 11/21/16
-
Is Pfizer Rethinking a Company Spin-Off?
Post on 11/21/16
-
5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them
Post on 11/21/16
-
Utz Quality Foods Opens New Health & Wellness Center
Post on 11/20/16
-
Immunomedics Comments on Receipt of Director Nominations
Post on 11/20/16
-
Johnson & Johnson Is Sitting On A Time Bomb
Post on 11/18/16
-
Aclaris Announces Pricing of Public Offering of Common Stock
Post on 11/18/16
-
Philadelphia Eagles, Jefferson, and Rothman Institute Announce Partnership Renewal
Post on 11/17/16
-
The Scariest Thing About Pfizer's Dividend
Post on 11/17/16
Philadelphia
